Clinical Trials on Hemophilia A, Hemophilia B in Hong Kong
Total 144 results
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia AUnited States, Hong Kong, Israel
-
Hoffmann-La RocheActive, not recruitingHemophilia AChina, Thailand, Hong Kong, Malaysia
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Hong KongCompletedExposure to Hepatitis B VirusHong Kong
-
The University of Hong KongCompletedChronic Hepatitis BHong Kong
-
The University of Hong KongGilead SciencesCompleted
-
Chinese University of Hong KongCompletedChronic Hepatitis BHong Kong
-
Humanity and Health Research CentreRecruitingChronic Hepatitis BHong Kong
-
The University of Hong KongCompletedExposure to Hepatitis B VirusHong Kong
-
The University of Hong KongRecruitingLiver Transplant; Complications | Occult Hepatitis BHong Kong
-
Novartis PharmaceuticalsCompleted
-
Chinese University of Hong KongUniversity of MalayaTerminatedImmunosuppression | Occult Hepatitis B | Biological Substance; Adverse EffectHong Kong
-
The University of Hong KongHospital Authority, Hong KongCompletedChronic Hepatitis B InfectionHong Kong
-
F-star Therapeutics, Inc.PRA Health SciencesTerminatedHepatitis B | Hepatitis B, Chronic | HBVHong Kong
-
The University of Hong KongNovartis PharmaceuticalsCompleted
-
Suzhou Ribo Life Science Co. Ltd.Completed
-
GlaxoSmithKlineCompletedChronic Hepatitis BHong Kong
-
Sanwa BioTech LimitedChinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong KongNot yet recruiting
-
The University of Hong KongCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Denmark, Austria, Spain, Japan, Brazil, Algeria, Lithuania, Portugal, Russian Federation, Serbia, Turkey, Greece, Hong Kong, Puerto Rico, Hungary, China, Poland
-
The University of Hong KongJanssen, LPUnknownFollicular Lymphoma | Chronic Hepatitis B | Chronic Lymphocytic Leukemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Indolent B-cell Lymphomas | Waldenstrom's MacroglobulinaemiaHong Kong
-
The University of Hong KongCompleted
-
Chinese University of Hong KongGlaxoSmithKline; Hoffmann-La RocheCompleted
-
Humanity and Health Research CentreRecruitingChronic Hepatitis B | Nonalcoholic Fatty Liver DiseaseChina
-
Chinese University of Hong KongGlaxoSmithKlineCompletedChronic Hepatitis BChina
-
Chinese University of Hong KongHoffmann-La RocheCompleted
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedSevere Hemophilia BSweden, United States, France, Italy, Russian Federation, United Kingdom, Germany, China, Poland, Japan, Australia, Brazil, Canada, India, South Africa, Hong Kong, Belgium
-
The University of Hong KongCompletedChronic Kidney Diseases | Hepatitis B, ChronicHong Kong
-
The University of Hong KongActive, not recruiting
-
Arrowhead PharmaceuticalsICON Clinical ResearchTerminated
-
Chinese University of Hong KongActive, not recruitingChronic Hepatitis BHong Kong
-
Hospital Authority, Hong KongCompleted
-
Bioverativ Therapeutics Inc.CompletedSevere Hemophilia BUnited States, Italy, Belgium, Australia, Brazil, Hong Kong, India, Ireland, Japan, South Africa, United Kingdom, Netherlands, Sweden, Canada, Poland, China, France, Germany
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical UniversityCompletedChronic Hepatitis C Infection | Hepatitis B Reactivation | HBV CoinfectionChina
-
Hospital Authority, Hong KongVigconic (International) Ltd.CompletedLiver Cirrhosis | Hepatitis B | Hepatitis CChina
-
The University of Hong KongCompletedHepatitis B | Inflammatory Bowel DiseasesChina
-
PfizerRecruitingHemophilia A | Hemophilia BHong Kong, Spain, Serbia, Turkey, United States, China, Mexico, South Africa, India, Japan, Croatia, Korea, Republic of, Oman, Taiwan, Italy, Canada, France
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
LG Life SciencesCompletedChronic Hepatitis BChina, Korea, Republic of
-
LG Life SciencesUnknownChronic Hepatitis BChina, Korea, Republic of
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Spain, Switzerland, Taiwan, Turkey, United Kingdom, Croatia, Germany, Brazil, France, Japan, Australia, Hungary, Israel, Korea, Republic of, Lithuania, Portugal, Ukraine, Greece, Italy, Denmark, Norway, Canada and more
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, United Kingdom, Croatia, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Italy, Japan, Norway, Bulgaria
-
PfizerActive, not recruitingHemophilia A | Hemophilia BUnited States, Spain, Canada, China, Korea, Republic of, Hong Kong, Serbia, Taiwan, Turkey, France, Oman, Saudi Arabia, Japan, India, South Africa, Mexico, Croatia, Italy, Bulgaria, Russian Federation
-
Gilead SciencesF-star Therapeutics, Inc.TerminatedChronic Hepatitis BKorea, Republic of, Hong Kong
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicHong Kong, China
-
SCG Cell Therapy Pte. Ltd.RecruitingHepatocellular Carcinoma Recurrent | Hepatitis B Virus Related Hepatocellular CarcinomaUnited States, Singapore, Hong Kong
-
Chinese University of Hong KongCompletedHIV Infections | Hepatitis B | Hepatocellular Carcinoma | Hepatitis CHong Kong
-
GlaxoSmithKlineIonis Pharmaceuticals, Inc.CompletedHepatitis B | Chronic Hepatitis B AtypicalKorea, Republic of, Hong Kong